Skip to main content

Main menu

  • HOME
  • LATEST ARTICLES
  • ALL ISSUES
  • AUTHORS & REVIEWERS
  • RESOURCES
    • About BJGP Open
    • BJGP Open Accessibility Statement
    • Editorial Board
    • Editorial Fellowships
    • Audio Abstracts
    • eLetters
    • Alerts
    • Outreach
    • BJGP Life
    • Research into Publication Science
    • Advertising
    • Contact
    • Top 10 Research Articles of the Year
  • SPECIAL ISSUES
    • Special issue: Telehealth
    • Special issue: Race and Racism in Primary Care
    • Special issue: COVID-19 and Primary Care
    • Past research calls
  • CONFERENCE
  • RCGP
    • British Journal of General Practice
    • BJGP for RCGP members
    • RCGP eLearning
    • InnovAIT Journal
    • Jobs and careers

User menu

  • Alerts

Search

  • Advanced search
Intended for Healthcare Professionals
BJGP Open
  • RCGP
    • British Journal of General Practice
    • BJGP for RCGP members
    • RCGP eLearning
    • InnovAIT Journal
    • Jobs and careers
  • Subscriptions
  • Alerts
  • Log in
  • Follow bjgp on Twitter
  • Visit bjgp on Facebook
  • Blog
BJGP Open
Intended for Healthcare Professionals

Advanced Search

  • HOME
  • LATEST ARTICLES
  • ALL ISSUES
  • AUTHORS & REVIEWERS
  • RESOURCES
    • About BJGP Open
    • BJGP Open Accessibility Statement
    • Editorial Board
    • Editorial Fellowships
    • Audio Abstracts
    • eLetters
    • Alerts
    • Outreach
    • BJGP Life
    • Research into Publication Science
    • Advertising
    • Contact
    • Top 10 Research Articles of the Year
  • SPECIAL ISSUES
    • Special issue: Telehealth
    • Special issue: Race and Racism in Primary Care
    • Special issue: COVID-19 and Primary Care
    • Past research calls
  • CONFERENCE
Practice & Policy

FASTer diagnosis: Time to BEAT heart failure

Clare J Taylor, Nick Hartshorne-Evans, Duwarakan Satchithananda and FD Richard Hobbs
BJGP Open 2021; 5 (3): BJGPO.2021.0006. DOI: https://doi.org/10.3399/BJGPO.2021.0006
Clare J Taylor
1 GP and NIHR Academic Clinical Lecturer, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
2 Clinical Board Member, Pumping Marvellous Foundation, Preston, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: clare.taylor@phc.ox.ac.uk
Nick Hartshorne-Evans
3 Chief Executive and Founder, Pumping Marvellous Foundation, Preston, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Duwarakan Satchithananda
2 Clinical Board Member, Pumping Marvellous Foundation, Preston, UK
4 Consultant Cardiologist, University Hospitals of North Midlands, Preston, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
FD Richard Hobbs
5 Professor and Head of Department, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info
  • eLetters
  • PDF
Loading
  • Heart failure
  • diagnosis
  • natriuretic peptide
  • testing
  • primary health care
  • general practice

Introduction

Heart failure (HF) is common and costly.1 Around 26 million people are living with HF globally, and a substantial proportion of healthcare budgets is spent on HF services.2 Large trials have established the clinical and cost-effectiveness of drug and device therapies which have symptomatic and prognostic benefit.3 However, HF survival rates have not improved substantially in the last two decades.4 Timely diagnosis is important to allow initiation of treatments which can improve outcome. Lack of HF awareness, barriers in the diagnostic pathway, suboptimal use of HF medications, and a low number of HF nurse specialists are just some factors that may have contributed to lack of progress over time.5

In this article, we explain the importance of diagnosing HF, highlight current challenges for primary care, and propose a novel approach for raising awareness of HF amongst patients, carers, and GPs.

Importance of diagnosis

Guidelines recommend that people with symptoms suggestive of HF presenting to primary care have a natriuretic peptide test, and referral for imaging and specialist review if the level is raised.3 However, a recent report by the British Heart Foundation highlighted that almost 80% of patients are diagnosed on emergency hospital admission, and called for earlier diagnosis in primary care.5

HF is a very treatable condition once diagnosed. It is categorised according to left ventricular ejection fraction: HF with reduced ejection fraction (HFrEF) and HF with preserved ejection fraction (HFpEF), and this distinction determines the most appropriate management pathway. There is a substantial evidence base for HFrEF treatments, which have been shown to improve quality of life, reduce hospitalisation, and increase survival.3 Prognostically beneficial treatments for HFpEF are more limited, but diagnosis remains important to explain symptoms and allow initiation of diuretic therapy to relieve fluid overload and intensification of treatment for existing risk factors.

Challenges for primary care

The primary care part of the HF diagnostic pathway requires patients to recognise that there is a problem and seek medical help, then for GPs to consider the possibility of HF and refer appropriately.6 The main symptoms of HF are breathlessness, fatigue, and ankle swelling, which often develop gradually. A symptom such as breathlessness can have many possible causes including obesity, lack of exercise, or another medical condition, such as lung disease. The average age for HF diagnosis is 76 years and most patients have multimorbidity.2

We conducted a qualitative interview study of patients with a recent diagnosis of HF. Our data showed that it was common for older patients to attribute their symptoms to being a normal part of ageing, or to a pre-existing long term condition.7 Family members were often first to notice that something was wrong and were instrumental in facilitating the initial contact with healthcare services.8

When patients present to primary care, the diagnosis of HF then needs to be considered; common symptoms found in HF can be attributed to other conditions by clinicians too. Analysis of primary care data has shown that there is often a significant delay between initial presentation and referral to specialist services, with missed opportunities for earlier diagnosis and treatment.9 Currently, four in five people with HF are hospitalised around the time of diagnosis, which is distressing for patients, costly to the health service, and usually denotes progression to a later stage of disease.

If HF is suspected, guidelines recommend a natriuretic peptide test; then, if the level is raised, referral for echocardiography and cardiology assessment. Variable availability of natriuretic peptide testing, limited capacity in echocardiography services, and long waiting times for cardiology outpatient appointments are potential barriers in the pathway. Recent data also shows in a cohort of patients referred for diagnostic assessment by their GP and seen by a cardiologist, only around 55% have a HF diagnosis.10 This means that almost half of patients will have an alternative diagnosis to explain their symptoms, further complicating the process and highlighting symptom overlap with other conditions such as lung disease.

Raising awareness through BEAT-HF

‘Heart failure’ is a frightening term and public awareness of HF as a condition is limited. HF has traditionally received less attention than other cardiovascular conditions, and this may partly contribute to delayed diagnosis. Images accompanying news reports about HF often feature a person clutching the middle of their chest which would be more representative of myocardial infarction.

It is important that patients and the public are aware of the symptoms of HF to be able to recognise the condition and seek help. Campaigns to prompt early action in serious illness have been a feature of previous public health interventions. Perhaps the most notable of these is the ‘Act FAST’ campaign to raise awareness of stroke symptoms. The FAST acronym stands for Face, Arms, Speech, then Time to call 999. The evidence for the effectiveness of the ‘Act FAST’ campaign is positive: patients, carers, and GPs reported awareness of the campaign, and an ability to distinguish stroke symptoms and take appropriate action.11

Inspired by FAST, we propose the BEAT-HF acronym to help patients, the public, and GPs to consider the possibility of HF. BEAT stands for Breathless, Exhausted, Ankle swelling, Time for a simple blood test (Figure 1). These three key symptoms in combination are common in people with HF. We conducted a diagnostic accuracy study of patients presenting with symptoms suggestive of HF to primary care.12 Our results showed that, in the patients diagnosed with HF, 80% reported breathlessness, 70% had fatigue, and 84% had ankle swelling.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1. BEAT-HF acronym (Pumping Marvellous Foundation social media campaign)

Success of the BEAT-HF campaign

The patient-led HF charity the Pumping Marvellous Foundation launched #BEATHF on Twitter in 2020. The initial tweet proposing the acronym has over 500 likes and retweets. We now hope that BEAT-HF will be adopted more widely in the healthcare sector, particularly amongst GPs, so clinicians consider HF as a diagnosis for anyone presenting with breathlessness, exhaustion, and ankle swelling.

Conclusion

Diagnosis is the key to treatment for people with HF. By raising awareness amongst patients, carers, and the wider public using BEAT-HF, people with symptoms may be more likely to see their doctor. Promoting BEAT-HF within primary care could prompt GPs to consider a diagnosis of HF, and test and refer at an earlier stage. By targeting these key points in the diagnostic pathway, this simple acronym may facilitate timely diagnosis, prevent costly hospital admissions, and allow earlier initiation of lifesaving treatments.

Notes

Funding

CT is a National Institute for Health Research funded Academic Clinical Lecturer. FDRH acknowledges support from the NIHR School for Primary Care Research, NIHR Applied Research Collaborative Oxford, and the NIHR Oxford Biomedical Research Centre. CT and RH lead the long-term conditions theme of the NIHR Community Healthcare Medtech In Vitro Diagnostics Co-operative. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health and Social Care.

Ethical approval

N/A

Provenance

Freely submitted; externally peer reviewed.

Competing interests

CT reports personal fees from Vifor and Novartis, and non-financial support from Roche outside the submitted work. NHE reports grants and other from AstraZeneca, Novartis, Vifor Pharma, Medtronic, Abbott, Boston Scientific and Roche outside the submitted work. DS reports personal fees from Pfizer and Alnylam, outside the submitted work. FDRH reports personal fees and other from Novartis and Boehringer Ingelheim, and grants from Pfizer outside the submitted work.

Acknowledgments

CT, NHE, and DS conceived the BEAT-HF acronym. The Pumping Marvellous Foundation are promoting the use of the BEAT-HF acronym to patients and the public. CT and FDRH are using the acronym in their ongoing heart failure research programme.

  • Received January 23, 2021.
  • Accepted March 4, 2021.
  • Copyright © 2021, The Authors

This article is Open Access: CC BY license (https://creativecommons.org/licenses/by/4.0/)

References

  1. 1.↵
    1. Conrad N,
    2. Judge A,
    3. Tran J,
    4. et al.
    (2018) Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals. Lancet 391(10120):572–580, doi:10.1016/S0140-6736(17)32520-5, pmid:29174292.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Savarese G,
    2. Lund LH
    (2017) Global public health burden of heart failure. Card Fail Rev 3(1):7–11, doi:10.15420/cfr.2016:25:2, pmid:28785469.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. National Institute for Health and Care Excellence
    (2018) Chronic heart failure in adults: diagnosis and management. NICE guideline [NG106]. https://www.nice.org.uk/guidance/ng106. 20 Apr 2021.
  4. 4.↵
    1. Taylor CJ,
    2. Ordóñez-Mena JM,
    3. Roalfe AK,
    4. et al.
    (2019) Trends in survival after a diagnosis of heart failure in the United Kingdom 2000-2017: population based cohort study. BMJ 364:l223, doi:10.1136/bmj.l223, pmid:30760447.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. British Heart Foundation
    (2020) Heart failure: a blueprint for change (BHF, London). https://www.bsh.org.uk/wp-content/uploads/2020/10/Heart-Failure-A-Blueprint-For-Change-Oct-2020-3.pdf.
  6. 6.↵
    1. Taylor CJ
    (2019) Diagnosing heart failure: challenges in primary care. Heart 105(9):663–664, doi:10.1136/heartjnl-2018-314396, pmid:30647095.
    OpenUrlFREE Full Text
  7. 7.↵
    1. Taylor CJ,
    2. Hobbs FDR,
    3. Marshall T,
    4. et al.
    (2017) From breathless to failure: symptom onset and diagnostic meaning in patients with heart failure-a qualitative study. BMJ Open 7(3), doi:10.1136/bmjopen-2016-013648, pmid:28283487. e013648.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Bell-Davies F,
    2. Goyder C,
    3. Gale N,
    4. et al.
    (2019) The role of informal carers in the diagnostic process of heart failure: a secondary qualitative analysis. BMC Cardiovasc Disord 19(1), doi:10.1186/s12872-019-1075-6, pmid:31014239. 92.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Bottle A,
    2. Kim D,
    3. Aylin P,
    4. et al.
    (2018) Routes to diagnosis of heart failure: observational study using linked data in England. Heart 104(7):600–605, doi:10.1136/heartjnl-2017-312183, pmid:28982720.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Zheng A,
    2. Cowan E,
    3. Mach L,
    4. et al.
    (2020) Characteristics and outcomes of patients with suspected heart failure referred in line with National Institute for Health and Care Excellence guidance. Heart 106(20):1579–1585, doi:10.1136/heartjnl-2019-316511, pmid:32690621.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Robinson TG,
    2. Reid A,
    3. Haunton VJ,
    4. et al.
    (2013) The face arm speech test: does it encourage rapid recognition of important stroke warning symptoms? Emerg Med J 30(6):467–471, doi:10.1136/emermed-2012-201471, pmid:22764171.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Taylor CJ,
    2. Roalfe AK,
    3. Iles R,
    4. et al.
    (2017) Primary care REFerral for EchocaRdiogram (REFER) in heart failure: a diagnostic accuracy study. Br J Gen Pract 67(655):e94–e102, doi:10.3399/bjgp16X688393, pmid:27919937.
    OpenUrlAbstract/FREE Full Text
Back to top
Previous ArticleNext Article

In this issue

BJGP Open
Vol. 5, Issue 3
June 2021
  • Table of Contents
  • Index by author
Download PDF
Download PowerPoint
Email Article

Thank you for recommending BJGP Open.

NOTE: We only request your email address so that the person to whom you are recommending the page knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
FASTer diagnosis: Time to BEAT heart failure
(Your Name) has forwarded a page to you from BJGP Open
(Your Name) thought you would like to see this page from BJGP Open.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
FASTer diagnosis: Time to BEAT heart failure
Clare J Taylor, Nick Hartshorne-Evans, Duwarakan Satchithananda, FD Richard Hobbs
BJGP Open 2021; 5 (3): BJGPO.2021.0006. DOI: 10.3399/BJGPO.2021.0006

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
FASTer diagnosis: Time to BEAT heart failure
Clare J Taylor, Nick Hartshorne-Evans, Duwarakan Satchithananda, FD Richard Hobbs
BJGP Open 2021; 5 (3): BJGPO.2021.0006. DOI: 10.3399/BJGPO.2021.0006
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
  • Mendeley logo Mendeley

Jump to section

  • Top
  • Article
    • Introduction
    • Conclusion
    • Notes
    • References
  • Figures & Data
  • Info
  • eLetters
  • PDF

Keywords

  • heart failure
  • diagnosis
  • natriuretic peptide
  • testing
  • primary health care
  • general practice

More in this TOC Section

  • Like, comment, subscribe: How journal editors can navigate social media competing interests
  • The BJGP Open Top 10 Most Read Research Articles of 2022: an editorial
  • Telehealth and primary care: a special collection from BJGP Open
Show more Practice & Policy

Related Articles

Cited By...

Intended for Healthcare Professionals

@BJGPOpen's Likes on Twitter

 
 

British Journal of General Practice

NAVIGATE

  • Home
  • Latest articles
  • Authors & reviewers
  • Accessibility statement

RCGP

  • British Journal of General Practice
  • BJGP for RCGP members
  • RCGP eLearning
  • InnovAiT Journal
  • Jobs and careers

MY ACCOUNT

  • RCGP members' login
  • Terms and conditions

NEWS AND UPDATES

  • About BJGP Open
  • Alerts
  • RSS feeds
  • Facebook
  • Twitter

AUTHORS & REVIEWERS

  • Submit an article
  • Writing for BJGP Open: research
  • Writing for BJGP Open: practice & policy
  • BJGP Open editorial process & policies
  • BJGP Open ethical guidelines
  • Peer review for BJGP Open

CUSTOMER SERVICES

  • Advertising
  • Open access licence

CONTRIBUTE

  • BJGP Life
  • eLetters
  • Feedback

CONTACT US

BJGP Open Journal Office
RCGP
30 Euston Square
London NW1 2FB
Tel: +44 (0)20 3188 7400
Email: bjgpopen@rcgp.org.uk

BJGP Open is an editorially-independent publication of the Royal College of General Practitioners

© 2023 BJGP Open

Online ISSN: 2398-3795